C. Randal Mills - Jun 21, 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for C. Randal Mills
Stock symbol
ELUT
Transactions as of
Jun 21, 2023
Transactions value $
-$18,731
Form type
4
Date filed
6/23/2023, 11:30 AM
Previous filing
Apr 28, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELUT Class A Common Stock Options Exercise +22.5K +46.81% 70.5K Jun 21, 2023 Direct F1
transaction ELUT Class A Common Stock Tax liability -$18.7K -7.77K -11.03% $2.41 62.7K Jun 21, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Restricted Stock Units Options Exercise $0 -22.5K -25% $0.00 67.4K Jun 21, 2023 Class A Common Stock 22.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2 Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3 On June 21, 2022, the Reporting Person was granted 89,893 restricted stock units, vesting in four substantially equal annual installments beginning in June 21, 2023.